contezolid
Selected indexed studies
- Contezolid: First Approval. (Drugs, 2021) [PMID:34365606]
- Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment. (Infection, 2024) [PMID:38717734]
- Contezolid in complicated skin and soft tissue infection. (Drugs Today (Barc), 2022) [PMID:35851867]
_Worker-drafted node — pending editorial review._
Connections
contezolid is a side effect of
Sources
- Contezolid: First Approval. (2021) pubmed
- Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment. (2024) pubmed
- Contezolid in complicated skin and soft tissue infection. (2022) pubmed
- Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis. (2023) pubmed
- The Therapeutic Effect of Contezolid in Complex Intra-Abdominal Infections. (2024) pubmed
- Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment. (2023) pubmed
- Contezolid, a novel oxazolidinone antibiotic, acts as a potential anti-inflammatory agent. (2025) pubmed
- Correction to: Contezolid: First Approval. (2021) pubmed
- Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients. (2023) pubmed
- Concentration of contezolid in cerebrospinal fluid and serum in a patient with tuberculous meningoencephalitis: A case report. (2023) pubmed